ByTrending Posts
How Unlearn AI Is Increasing the Efficiency of…
December 11, 2024 Enhanced TwinRCT™ 3.0 Unlearn® has introduced an upgraded version of its AI-driven TwinRCT™ solution—TwinRCT 3.0,…
Relation Therapeutics, NVIDIA-Backed AI-Biotech, and GSK Announce Strategic…
London, UK – December 10, 2024 Relation, a leader in computational and experimental drug discovery, has announced two…
Recursion Reports Promising Interim Data for AI-Designed CDK7…
Salt Lake City – December 9, 2024 Recursion (Nasdaq: RXRX), a leader in AI-powered drug discovery, has released…
Recursion Doses First Patient in Phase 1/2 Trial…
Recursion (NASDAQ: RXRX), a cutting-edge clinical-stage TechBio company, has announced the successful dosing of the first patient in…
AI Drug Discovery Leaders Recursion and Exscientia Merge…
Recursion and Exscientia, two trailblazers in AI-driven drug discovery, have officially merged to form a technology-powered platform aimed…
NVIDIA Expands AI-Driven Drug Discovery with BioNeMo Framework
November 18, 2024 NVIDIA has launched a major initiative to scale AI-powered drug discovery through the open-source BioNeMo…
ImmunAI and Teva Partner to Enhance Clinical Trials…
New York, NY – Nov 14, 2024 Strategic Collaboration Aims to Improve Drug Development Efficiency and Patient Outcomes:ImmunAI,…
Medable and Google Cloud Partner to Advance AI-Powered…
PALO ALTO, Calif. – October 30, 2024 Strategic Collaboration to Accelerate Clinical Research Medable Inc., a leader in…
Odyssey and Terray Forge AI-Powered Partnership to Advance…
Boston and Los Angeles – Oct 28, 2024 With Odyssey’s established track record in immunology and Terray’s cutting-edge…
Trending Posts
Latest Stories
The Best Feeling Is When Our Drugs Succeed”: Dame Emma Walmsley Reflects on GSK’s Legacy of Innovation
London | December 2025 GlaxoSmithKline (GSK) today highlighted a defining reflection from its outgoing Chief…
Neuroscience Biopharma in Transformation: Pipeline and Commercial Dynamics Reshape the Industry
Washington, D.C. — The neuroscience segment is undergoing a significant strategic transformation, driven by breakthroughs…
How Will New U.S. Drug Pricing Policies Reshape the Pharmaceutical Ecosystem?
Washington, D.C. — December 29, 2025 — Recent changes in U.S. drug pricing policies are…
How Did Merck’s 2025 Deals Strengthen Its Pipeline and What Could They Mean for Future Growth?
In 2025, Merck pursued a series of high-impact collaborations, acquisitions, and licensing agreements to expand…
Gallery
